Short answer · Medically reviewed summary · Last updated: 2026-05-08
The ICD-10-CM code for Relapsing Polychondritis is M94.1, while the corresponding ICD-9-CM code is 733.99. These diagnostic codes are essential for healthcare providers to document this rare, systemic inflammatory condition characterized by recurrent episodes of inflammation and cartilage destruction. What is the clinical nature of Relapsing Polychondritis? Relapsing Polychondritis is a chronic, episodic, multisystemic autoimmune disorder.
11 people with Relapsing Polychondritis have shared their first-person experience on this question at DiseaseMaps.
The ICD-10-CM code for Relapsing Polychondritis is M94.1, while the corresponding ICD-9-CM code is 733.99. These diagnostic codes are essential for healthcare providers to document this rare, systemic inflammatory condition characterized by recurrent episodes of inflammation and cartilage destruction.
Relapsing Polychondritis is a chronic, episodic, multisystemic autoimmune disorder. It primarily affects the cartilaginous structures of the body, including the ears, nose, and respiratory tract. Because Relapsing Polychondritis can also impact the eyes, heart, and joints, it requires a multidisciplinary approach to management. Currently, our DiseaseMaps.org community includes 468 members living with this condition, highlighting the importance of shared experiences in navigating this rare diagnosis.
There is no single "gold standard" test for Relapsing Polychondritis; diagnosis is primarily clinical. Physicians often utilize the McAdam criteria or subsequent modifications, which look for the presence of at least three of the following clinical features:
The management of Relapsing Polychondritis focuses on suppressing systemic inflammation to prevent the permanent structural damage that occurs as cartilage is degraded. Treatment typically involves corticosteroids like prednisone for acute flares, often supplemented by disease-modifying antirheumatic drugs (DMARDs) such as methotrexate, azathioprine, or biologics like infliximab to maintain remission.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the guidance of your physician regarding any medical condition.